Medite Cancer Diagnostics Inc - ESG Rating & Company Profile powered by AI
Jump to the bottom of this webpage for potential risks for Medite Cancer Diagnostics Inc based on industry, location and marketcap. If you are employed by Medite Cancer Diagnostics Inc and you would like to licence your ESG rating, please contact us. Comprehensive ESG assessment of Medite Cancer Diagnostics Inc can be accessed by logging in.
Medite Cancer Diagnostics Inc in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Calmark Sweden AB | 8.0 | High |
| 1 | CHC Healthcare Group | 8.0 | High |
| ... | ... | ... | |
| 256 | Mazor Robotics Ltd | 0.5 | Low |
| 259 | Edan Instruments Inc | 0.4 | Low |
| 260 | Medite Cancer Diagnostics Inc | 0.0 | Low |
| 260 | Cableclix USA Inc | 0.0 | Low |
| 260 | Caduceus Software Systems Corp | 0.0 | Low |
| 260 | Zhuhai Hokai Medical Instruments Co Ltd | 0.0 | Low |
| 260 | Zynex Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Medite Cancer Diagnostics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc report the average age of the workforce?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc offer flexible work?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc conduct supply chain audits?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose water use targets?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Medite Cancer Diagnostics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Medite Cancer Diagnostics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Medite Cancer Diagnostics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose its waste policy?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose energy use targets?
Sign up for free to unlockDoes Medite Cancer Diagnostics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Medite Cancer Diagnostics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Medite Cancer Diagnostics Inc
These potential risks are based on the size, segment and geographies of the company.
Medite Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC 15 Duo and Trio, a tissue processing instrument; TES 99 and TES Valida cooling units; and M530, A550, M380 microtomes for tissue sectioning. It also provides M630, a freezing microtome; TST44, a robotic multi-staining system; COT 20, a linear staining system; and RCM 9000, ACS 720, and TWISTER robotic coverslippers. In addition, the company develops SoftKit device for the self-collection of a sample that can be evaluated to provide an assessment of the health of the entire female genital tract. It sells its products through direct sales and distributors in the United States, China, Europe, and North Africa. The company serves histology and cytology laboratories associated with hospitals or research institutions, and independent laboratories. Medite Cancer Diagnostics, Inc. is based in Orlando, Florida.